| Basics |
Galapagos NV
Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions.
|
| IPO Date: |
March 1, 2012 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$2.2B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.90 | 1.16%
|
| Avg Daily Range (30 D): |
$0.51 | 1.60%
|
| Avg Daily Range (90 D): |
$0.39 | 1.31%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.31M |
| Avg Daily Volume (90 D): |
.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
75 |
| Avg Trade Size (Sh.) (30 D): |
71 |
| Avg Trade Size (Sh.) (90 D): |
65 |
| Institutional Trades |
| Total Inst.Trades: |
1,182 |
| Avg Inst. Trade: |
$2.44M |
| Avg Inst. Trade (30 D): |
$1.23M |
| Avg Inst. Trade (90 D): |
$1.27M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.95M |
| Avg Closing Trade (30 D): |
$.81M |
| Avg Closing Trade (90 D): |
$.93M |
| Avg Closing Volume: |
33.88K |
|
|
|
|
|
